Growth Metrics

Myomo (MYO) Other Non-Current Liabilities (2017 - 2025)

Myomo posted quarterly Other Non-Current Liabilities of $1.6 million for Q4 2025, up 1354.67% on a QoQ basis from $113423.0 in Q3 2021.

Myomo (MYO) has 6 years of Other Non-Current Liabilities data on file, last reported at $1.6 million in Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Liabilities changed N/A year-over-year to $1.6 million; the trailing twelve-month figure through Dec 2025 stood at $1.6 million (changed N/A YoY), and the FY2025 full-year result was $1.6 million, changed N/A from the prior year.
  • Other Non-Current Liabilities for Q4 2025 stood at $1.6 million, up from $113423.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $1.6 million in Q4 2025 and bottomed at $113423.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Myomo 44.63 Mn 26.23 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.65 Mn
Sep 30, 2021 113,423.00
Jun 30, 2021 113,423.00
Mar 31, 2021 113,423.00
Dec 31, 2020 118,060.00
Sep 30, 2020 165,889.00
Jun 30, 2020 888.00
Mar 31, 2020 40,605.00
Dec 31, 2019 378,239.00
Sep 30, 2019 43,942.00
Jun 30, 2019 58,477.00
Mar 31, 2019 157,926.00
Dec 31, 2018 3,661.00
Jun 30, 2018 21,962.00
Mar 31, 2018 24,623.00
Dec 31, 2017 39,930.00
Sep 30, 2017 92,359.00
Jun 30, 2017 311,733.00